Advertisement

Irish Journal of Medical Science

, Volume 180, Issue 1, pp 271–273 | Cite as

Primary cardiac lymphoma: diagnostic tools and treatment challenges

  • R. Bambury
  • F. Gallagher
  • J. D. Dodd
  • D. Fennelly
Case Report

Abstract

Primary cardiac lymphoma (PCL) is a rare malignancy and the optimal treatment strategy remains uncertain. It appears to respond much better to systemic chemotherapy than to surgery and it should be considered in the differential diagnosis of all cardiac tumours before definitive management is undertaken. We report a case of this rare disorder treated successfully with a combination of rituximab and cyclophosphamide, adriamycin, vincristine and prednisolone. The patient developed recurrent unstable ventricular tachycardia (VT) post-chemotherapy secondary to extensive scarring at the tumour site. The tumour as well as the post-treatment scarring is well illustrated by cardiac magnetic resonance imaging highlighting its usefulness in this setting. An implantable cardioverter defibrillator (ICD) was placed. This is only the second case in the literature of PCL to have an ICD placed for recurrent VT. A brief literature review is included.

Keywords

Primary cardiac lymphoma Cardiac tumours Non-Hodgkins lymphoma 

Notes

Conflict of interest statement

None.

References

  1. 1.
    Burke A, Virmani R (1996) Tumours of the heart and great vessels. In: Rosai J, Sobin LH (eds) Atlas of tumour pathology, 3rd Series, Fasicle 16. Armed Forces Institute of Pathology, Washington DC, pp 171–179Google Scholar
  2. 2.
    Rolla G, Bertero MT, Pastena G et al (2002) Primary lymphoma of the heart. A case report and review of the literature. Leuk Res 26:117–120. doi: 10.1016/S0145-2126(01)00092-3 CrossRefPubMedGoogle Scholar
  3. 3.
    Chalabreysse L, Berger F, Loire R et al (2002) Primary Cardiac Lymphoma in immunocompetent patients: report of three cases and review of the literature. Virchows Arch 441:456–461. doi: 10.1007/s00428-002-0711-0 CrossRefPubMedGoogle Scholar
  4. 4.
    Miyashita T, Miyazawa I, Kawaguchi T, Kasai T, Yamaura T (2000) A case of primary cardiac B cell lymphoma associated with ventricular tachycardia, successfully treated with systemic chemotherapy and radiotherapy: a long-term survival case. Jpn Circ J 64(2):135–138. doi: 10.1253/jcj.64.135 CrossRefPubMedGoogle Scholar
  5. 5.
    Moon JC, McKenna WJ, McCrohon JA et al (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41:1561–1567. doi: 10.1016/S0735-1097(03)00189-X CrossRefPubMedGoogle Scholar
  6. 6.
    Kohl O, Hölschermann H, Pralle H et al (2000) Therapy-resistant ventricular tachycardia in a woman with primary cardiac non-Hodgkin lymphoma. Med Klin (Munich) 95:517–522. doi: 10.1007/PL00002141 CrossRefGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2009

Authors and Affiliations

  • R. Bambury
    • 1
  • F. Gallagher
    • 1
  • J. D. Dodd
    • 2
  • D. Fennelly
    • 1
  1. 1.Department of Medical OncologySt Vincents University HospitalDublin 4Ireland
  2. 2.Department of RadiologySt Vincents University HospitalDublin 4Ireland

Personalised recommendations